Industry News
First observation of human HAT, key proteins in numerous pathologies
Feb 13, 2014
Researchers at IRB Barcelona, BSC, and the University of Bern observe the first structure of a human HAT at low resolution.HAT amino acid transporters are involved in pathologies such as aminoacidurias, cancer, viral infections and cocaine addiction. Read More
Potential for targeting aggressive breast cancers shown by new UK study
Feb 13, 2014
A new study led by University of Kentucky Markey Cancer Center researcher Peter Zhou shows that targeting Twist, a nuclear protein that is an accelerant of the epithelial-mesenchymal transition (EMT) program in human cells, may provide an effective approach for treating triple-negative breast cancer. Read More
Bladder cancer subtypes genetically similar to breast cancer subtypes
Feb 13, 2014
Researchers at the UNC School of Medicine conducted a comprehensive genetic analysis of invasive bladder cancer tumors to discover that the disease shares genetic similarities with two forms of breast cancer. Read More
Potential to predict breast cancer survival by testing for fifty-five genes linked to a powerful tumor suppressor
Feb 13, 2014
A panel of 55 genes, almost all of which are impacted by the loss of a particular protein, appears to predict if breast cancer will become invasive, leading to poorer survival, researchers at Georgetown Lombardi Comprehensive Cancer Center report in PLOS ONE. Read More
New target isolated for acute myeloid leukemia drug development
Feb 13, 2014
There are potentially effective treatments for acute myeloid leukemia (AML), but they only work in 20 to 40 percent of cases. Read More
Key cellular pathway identified in prostate cancer
Feb 13, 2014
Mayo Clinic researchers have shed light on a new mechanism by which prostate cancer develops in men. Central to development of nearly all prostate cancer cases are malfunctions in the androgen receptor - the cellular component that binds to male hormones. Read More
The challenge of accurate diagnosis of Rare Cancers
Feb 13, 2014
Inaccurate diagnosis is a major obstacle for the proper treatment of patients with rare cancers. A Consensus on Improving the Pathologic Diagnosis of Rare Cancers (1) was presented today by Rare Cancers Europe, together with the European Society for Medical Oncology (ESMO) and the European Society of Pathology (ESP) in Brussels. Read More
From surgery to laboratory and back again
Feb 13, 2014
A University of York scientist's experience in seeing his partner in hospital recovering from a double lung transplant prompted him to design and synthesise new chemical agents that could revolutionise post-operative patient care. Read More
Key cellular pathway identified in prostate cancer
Feb 13, 2014
Mayo Clinic researchers have shed light on a new mechanism by which prostate cancer develops in men. Central to development of nearly all prostate cancer cases are malfunctions in the androgen receptor - the cellular component that binds to male hormones. Read More
From surgery to laboratory and back again
Feb 13, 2014
A University of York scientist's experience in seeing his partner in hospital recovering from a double lung transplant prompted him to design and synthesise new chemical agents that could revolutionise post-operative patient care. Read More
Previous Page Next Page